We are monitoring the impact of COVID-19 on APAC Cancer Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2149
Share on
Share on

Asia Pacific Cancer Biomarkers Market Research Report – Segmented By Disease, Services, Application, Type, Profiling Technologies, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis on Size, Share, Trends, Growth, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 2149
Pages: 145

APAC Cancer Biomarkers Market Size (2020 to 2025)

The size of the Cancer Biomarkers Market in the Asia Pacific was worth USD 2.57 billion in 2019 and is estimated to be growing at a CAGR of 12.6% to reach USD 4.66 billion by 2024. The Asia-Pacific market is expected to grow at a fast pace with consistent economic development.

Cancer biomarkers are substances that are indicative of the presence of cancer in the body. With the emerging importance of quantifying and validate various disease conditions, many organizations, companies, and universities have stepped forward to contribute to the field of biomarkers discovery and quantification for better prognosis of disease conditions.

The Biomarkers in the pharmaceutical industry, biomarkers in oncology & other diseases have attained full recognition due to the global spread of cancer and other diseases. Factors such as technological developments in omics technologies augmented demand for personalized medicines in cancer therapies, and increased use of biomarkers in drug discovery development and clinical trials are anticipated to boost the cancer biomarkers market's growth during the forecast period. 

Lack of awareness about the procedure among people is restraining market growth.

APAC Cancer Biomarkers Market segmented and sub-segmented into the following categories.

  • By Disease: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Other Cancers
  • By Services: Sample Preparation, Assay Development, and Biomarkers Validation And Testing
  • By Application: Risk Assessment, Development Of Molecular Diagnostics, Disease Diagnosis, Drug Discovery And Development And Drug Formulation
  • By Type: Protein Biomarkers, Genetic Biomarkers, and Other Biomarkers
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Based on the region, China dominates the cancer biomarkers market and is estimated to grow at the highest CAGR in the forecast period. China is expected to grow with a CAGR of 11.8% from 2020 to 2025 due to the growing R&D activities, investments from the government, and rising adoption of personalized medicine. 

The cancer biomarkers in India are expected to register a CAGR of 16.0% during the forecast period due to its large population base and tremendous death rate. Early diagnosis of cancer results in lessening of economic stress over the population and government. 

The Japanese cancer biomarkers market is estimated to showcase a CAGR of 11.9% from 2020 to 2025, and the Y-O-Y death rate in Japan is significantly increasing. Around 1.1 million cancer cases were registered, out of which 149,500 cases are of colon cancer, followed by 132,800 cases of stomach cancer, and 128,700 cases of lung cancer were registered. The growing aging population may boost cancer biomarkers market growth during the forecast period.

Australia's cancer biomarkers market to have noticeable growth during the forecast period due to new protein biomarkers by the government organizations. In both men and women, colorectal cancer, which is the most common cancer, is seen in people above 50years of age, and about 5,375 deaths were caused to end by this colorectal cancer. Moreover, collaborations and partnerships among the government organizations and other pharmaceutical companies to improve biomarkers are expected to surge the market of this region.

Key market participants in the APAC Cancer Biomarkers Market profiled in this report are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Disease
      1. Introduction
      2. Prostate Cancer
      3. Breast Cancer
      4. Lung Cancer
      5. Colorectal Cancer
      6. Cervical Cancer
      7. Other Cancer
      8.   Y-o-Y Growth Analysis, By Disease
      9.   Market Attractiveness Analysis, By Disease
      10.   Market Share Analysis, By Disease
    2. By Application
      1. Introduction
      2. Risk Assessment
      3. Development of molecular diagnostics
      4. Disease diagnosis
      5. Drug discovery
      6. Development and Drug formulation
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
    3. By Services
      1. Sample Preparation
      2. Assay development
      3. Biomarkers validation and testing
      4. Y-o-Y Growth Analysis, By Services
      5. Market Attractiveness Analysis, By Services
      6. Market Share Analysis, By Services
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
    2. North America
      1. Introduction
      2. US
      3. Canada
      4. Mexico
      5. Rest of North America
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Russia
      8. Sweden
      9. Denmark
      10. Switzerland
      11. Netherlands
      12. Turkey
      13. Czech Republic
      14. Rest of Europe
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
      7. New Zealand
      8. Thailand
      9. Malaysia
      10. Vietnam
      11. Philippines
      12. Indonesia
      13. Singapore
      14. Rest of APAC
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Chile
      5. Rest of Latin America
    6. Middle East & Africa
      1. Introduction
      2. KSA
      3. UAE
      4. Israel
      5. Rest of GCC countries
      6. South Africa
      7. Ethiopia
      8. Kenya
      9. Egypt
      10. Sudan
      11. Rest of MEA
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Abbott Laboratories
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Agendia Bv
    3. Biocurex Inc.
    4. Biomerieux S.A
    5. Biomoda Inc.
    6. Astellas Pharma Us Inc.
    7. Correlogic Systems Inc.
    8. Beckman Coulter Inc.
    9. Becton Dickinson and Company
    10. Clarient Inc.
    11. Diadexus Inc.
    12. Ambrilia Biopharma
    13. Affymetrix Inc.
    14. Aureon Laboratories Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Cancer Biomarkers Market, By Disease, From 2020 to 2025 (USD Million)
  2. Asia-Pacific Prostate Cancer Market, By Region, From 2020 to 2025 (USD Million)
  3. Asia-Pacific Breast Cancer Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia-Pacific Lung Cancer Market, By Region, From 2020 to 2025 (USD Million)
  5. Asia-Pacific Colorectal Cancer Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia-Pacific Cervical Cancer  Market, By Region, From 2020 to 2025 (USD Million)
  7. Asia-Pacific Other Cancers Market, By Region, From 2020 to 2025 (USD Million)
  8. Asia-Pacific Cancer Biomarkers Market, By Services, From 2020 to 2025 (USD Million)
  9. Asia-Pacific Sample Preparation Market, By Region, From 2020 to 2025 (USD Million)
  10. Asia-Pacific Assay development  Market, By Region, From 2020 to 2025 (USD Million)
  11. Asia-Pacific Biomarkers validation and testing Market, By Region, From 2020 to 2025 (USD Million)
  12. Asia-Pacific Cancer Biomarkers Market, By Application, From 2020 to 2025 (USD Million)
  13. Asia-Pacific Risk Assessment Market, By Region, From 2020 to 2025 (USD Million)
  14. Asia-Pacific Development of molecular diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  15. Asia-Pacific Disease diagnosis Market, By Region, From 2020 to 2025 (USD Million)
  16. Asia-Pacific Drug discovery  Market, By Region, From 2020 to 2025 (USD Million)
  17. Asia-Pacific Development and Drug formulation Market, By Region, From 2020 to 2025 (USD Million)
  18. Asia-Pacific Cancer Biomarkers Market, By Type, From 2020 to 2025 (USD Million)
  19. Asia-Pacific Protein Biomarkers Market, By Region, From 2020 to 2025 (USD Million)
  20. Asia-Pacific Genetic biomarkers  Market, By Region, From 2020 to 2025 (USD Million)
  21. Asia-Pacific Other biomarkers Market, By Region, From 2020 to 2025 (USD Million)
  22. Asia-Pacific Cancer Biomarkers Market, By Profiling Technologies , From 2020 to 2025 (USD Million)
  23. Asia-Pacific Omics technologies  Market, By Region, From 2020 to 2025 (USD Million)
  24. Asia-Pacific Imaging technologies Market, By Region, From 2020 to 2025 (USD Million)
  25. Asia-Pacific Immunoassays Market, By Region, From 2020 to 2025 (USD Million)
  26. Asia-Pacific Cytogenetics Market, By Region, From 2020 to 2025 (USD Million)
  27. Asia-Pacific Bioinformatics Market, By Region, From 2020 to 2025 (USD Million)
  28. Asia-Pacific IVD multivariate index assays Market, By Region, From 2020 to 2025 (USD Million)
  29. Japan Cancer Biomarkers Market, By Disease, From 2020 to 2025 (USD Million)
  30. Japan Cancer Biomarkers Market, By Services, From 2020 to 2025 (USD Million)
  31. Japan Cancer Biomarkers Market, By Application, From 2020 to 2025 (USD Million)
  32. Japan Cancer Biomarkers Market, By Type, From 2020 to 2025 (USD Million)
  33. Japan Cancer Biomarkers Market, By Profiling Technologies , From 2020 to 2025 (USD Million)
  34. China Cancer Biomarkers Market, By Disease, From 2020 to 2025 (USD Million)
  35. China Cancer Biomarkers Market, By Services, From 2020 to 2025 (USD Million)
  36. China Cancer Biomarkers Market, By Application, From 2020 to 2025 (USD Million)
  37. China Cancer Biomarkers Market, By Type, From 2020 to 2025 (USD Million)
  38. China Cancer Biomarkers Market, By Profiling Technologies , From 2020 to 2025 (USD Million)
  39. India Cancer Biomarkers Market, By Disease, From 2020 to 2025 (USD Million)
  40. India Cancer Biomarkers Market, By Services, From 2020 to 2025 (USD Million)
  41. India Cancer Biomarkers Market, By Application, From 2020 to 2025 (USD Million)
  42. India Cancer Biomarkers Market, By Type, From 2020 to 2025 (USD Million)
  43. India Cancer Biomarkers Market, By Profiling Technologies , From 2020 to 2025 (USD Million)
  44. Australia Cancer Biomarkers Market, By Disease, From 2020 to 2025 (USD Million)
  45. Australia Cancer Biomarkers Market, By Services, From 2020 to 2025 (USD Million)
  46. Australia Cancer Biomarkers Market, By Application, From 2020 to 2025 (USD Million)
  47. Australia Cancer Biomarkers Market, By Type, From 2020 to 2025 (USD Million)
  48. Australia Cancer Biomarkers Market, By Profiling Technologies , From 2020 to 2025 (USD Million)
  49. South Korea Cancer Biomarkers Market, By Disease, From 2020 to 2025 (USD Million)
  50. South Korea Cancer Biomarkers Market, By Services, From 2020 to 2025 (USD Million)
  51. South Korea Cancer Biomarkers Market, By Application, From 2020 to 2025 (USD Million)
  52. South Korea Cancer Biomarkers Market, By Type, From 2020 to 2025 (USD Million)
  53. South Korea Cancer Biomarkers Market, By Profiling Technologies , From 2020 to 2025 (USD Million)
  54. Asia-Pacific Cancer Biomarkers Market, By Omics technologies , From 2020 to 2025 (USD Million)
  55. Asia-Pacific Genomics Market, By Region, From 2020 to 2025 (USD Million)
  56. Asia-Pacific Proteomics Market, By Region, From 2020 to 2025 (USD Million)
  57. Asia-Pacific Metabolomics Market, By Region, From 2020 to 2025 (USD Million)
  58. Asia-Pacific Transcriptomics Market, By Region, From 2020 to 2025 (USD Million)
  59. Asia-Pacific Pharmacogenomics Market, By Region, From 2020 to 2025 (USD Million)
  60. Japan Cancer Biomarkers Market, By Omics technologies , From 2020 to 2025 (USD Million)
  61. China Cancer Biomarkers Market, By Omics technologies , From 2020 to 2025 (USD Million)
  62. India Cancer Biomarkers Market, By Omics technologies , From 2020 to 2025 (USD Million)
  63. Australia Cancer Biomarkers Market, By Omics technologies , From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample